tert-Butyl 14-hydroxy-3,6,9,12-tetraoxatetradecan-1-oate, 95.0%, 1g

8-Bromo-4-chloro-7-methoxy-1,6-naphthyridine, 95.0%, 100mg

Gly-Gly-Gly-PEG4-DBCO, 5mg

Nalpha-[(9H-Fluoren-9-ylmethoxy)carbonyl]-O-tert-butyl-D-tyrosine>98.0%(HPLC)(T)5g

N1-(1-benzylpiperidin-4-yl)benzene-1,2-diamine, 95+%, 1g

N-(3,5-bis(trifluoromethyl)benzyl)-7,9-dimethyl-N-(2-methyl-2H-tetrazol-5-yl)-2,3,4,5-tetrahydro-1H-benzo[b]azepin-5-amine, 98%, 100mg

(S)-Methyl 2-amino-3-(5-methylpyridin-2-yl)propanoate hydrochloride, 95.0%, 1g

8-cyclopentyl-8-oxooctanoic acid, 97.0%, 1g

Ethyl 1-(azetidin-3-yl)-1H-1,2,3-triazole-4-carboxylate hydrochloride, 100mg

(2E)-3-(2,5-dimethoxyphenyl)-1-(3-nitrophenyl)prop-2-en-1-one, 95.0%, 10g

(R)-1-(2-Fluorophenyl)ethylamine hydrochloride, 95.0%, 1g

Flacon rond 500 ml LDPE blanc RD 32 cylindrique

Ethyl 3-(pyridin-2-yl)propanoate, 95.0%, 5g